SCHEMBL20629013

SCHEMBL20629013

Cc1nn(Cc2cc(Cl)ccc2OCC(C)C)c2ccc(C(O)O)cc12

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTGER1 P34995 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15076266 0.84 PTGER1 (0.57) PTGER1
SCHEMBL20628803 0.84 PTGER1 (0.38) PTGER1
SCHEMBL15076264 0.75 PTGER1 (0.46) PTGER1
SCHEMBL13693234 0.74 PTGER1 (0.71) PTGER1
SCHEMBL15058113 0.74 PTGER1 (0.56) PTGER1
SCHEMBL13844985 0.74 PTGER1 (0.71) PTGER1
SCHEMBL15053916 0.73 PTGER1 (0.46) PTGER1
SCHEMBL4085182 0.72 PTGER1 (0.71) PTGER1
SCHEMBL13694798 0.72 PTGER1 (0.61) PTGER1
SCHEMBL15057643 0.71 PTGER1 (0.42) PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424904-A1 COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE Allergan, Inc. (US) 2019-01-09 — — EP disclosed
Send feedback